Barley and CKD in childre
Phase 2
Not yet recruiting
- Conditions
- PaediatricsKidney Disease
- Registration Number
- PACTR202202482995099
- Lead Sponsor
- the investigators
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1.Age between 6 and 14 years
2.Chronic kidney disease (CKD) stage 3-4 of any etiology, with an estimated GFR of <60mL/min/1.73m2 by Schwartz formula
3.Urine output more than 1ml/kg/h to avoid any possibility of fluid overload by administering barley extract.
Exclusion Criteria
1-Unwilling to participate in the study.
2-Comorbid diseases unrelated to CKD include diabetes mellitus, structural heart disease, active liver disease, pancreatic insufficiency, or Celiac disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does barley extract target in pediatric chronic kidney disease progression?
How does barley extract compare to standard-of-care treatments for pediatric CKD in clinical trials?
Which biomarkers are associated with response to barley extract in pediatric chronic kidney disease?
What are the potential adverse events of barley extract in children with chronic kidney disease?
Are there any combination therapies involving barley extract for pediatric CKD treatment?